Observational analysis showed that thrombocytosis predicts disease progression in patients with NPC, indicating intensive chemotherapy may be necessary.
Thrombocytosis occurring before or during treatment serves as a valuable predictor of disease progression and poor prognosis in patients with NPC. Patients presenting with thrombocytosis may require more intensive therapeutic strategies; therefore, the presence of thrombocytosis should be considered when selecting an induction chemotherapy regimen. Further prospective studies are warranted to confirm these findings.
No takes yet. Share an insight, caveat, or question.
Su et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: